Bone Therapeutics to present data at Herbert Fleisch / IFMRS Workshop
Gosselies, Belgium, 18 March 2019, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, today announces that the Company will present a poster at the 2019 Herbert Fleisch / International Federation of Musculoskeletal Research Societies (IFMRS) Workshop “Advancing today’s research; Fostering tomorrow’s leaders” from 17 to 19 March 2019 in Bruges, Belgium.
The IFMRS is an international, not-for-profit federation of musculoskeletal research societies dedicated to promoting excellence in the field of bone and mineral research. The IFMRS mission is to advance musculoskeletal research globally in order to prevent and treat musculoskeletal diseases by collaborating with international societies to share resources, raise public awareness and provide education.
In the poster presentation, Bone Therapeutics will highlight the in vitro chondro-osteogenic characteristics and the potent in vivo osteogenic properties of its proprietary allogenic ex vivo differentiated bone-forming cells derived from human bone marrow Mesenchymal Stem Cells (MSC).
Poster Title: Bone-forming cells differentiated ex vivo from human bone marrow MSC display chondro-osteogenic characteristics in vitro and potent osteogenic properties in vivo
Authors: Sylvain Normand 1, Delphine De Troy 1, Laure Hertzog 1, Anna Tury 2, Roland Baron 3, Sandra Pietri 1
Poster number: 127
Date: 17-19 March 2019
Location: Novotel Hotel, Bruges, Belgium
(1 Bone Therapeutics S.A., Gosselies, Belgium, 2 Skeletal Cell Therapy Support S.A., Gosselies, Belgium, 3 Harvard Medical School, Boston, MA, USA)